10x Genomics Inc Ordinary Shares - Class A (TXG)

Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell

$8.87

Buy

$9.05

arrow-up$0.27 (+3.14%)

Prices updated at 29 May 2025, 00:41 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.51%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Health Information Services
Chairman
Mr. John R. Stuelpnagel, D.V.M.
CEO
Dr. Serge Saxonov, PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
1,306
Head office
6230 Stoneridge Mall Road
Pleasanton
United States
94588
mobile
+1 925 401-7300
letter
investors@10xgenomics.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Eric S. Whitaker
Chief Legal Officer
0.48m--7.00m-
Mr. John R. Stuelpnagel, D.V.M.
Chairman of the Board
0.13m--0.32m-
Ms. Kimberly J. Popovits
Independent Director
0.07m--0.26m-
Mr. Alan V. Mateo
Independent Director
0.03m--0.48m-
Dr. Shehnaaz Suliman, M.D.
Independent Director
0.07m--0.25m-
Dr. Serge Saxonov, PhD
Chief Executive Officer and Director
0.63m--7.93m-
Dr. Benjamin J. Hindson, PhD
Director, Chief Scientific Officer and President
0.49m--4.27m-
Mr. Sridhar Kosaraju
Independent Director
0.08m--0.26m-
Mr. Adam S. Taich
Chief Financial Officer and Principal Accounting Officer
0.19m--3.30m-
Dr. Sarah A. Teichmann
Independent Director
0.03m--0.47m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
ARK Investment Management LLC12,845,7131.122489016567.54899330 Apr 202510.43
Vanguard Group Inc. ( Junked)10,972,930-196159821.76812530 Apr 20259.06
Vanguard Group Inc11,118,0860.001751845371.68780530 Apr 20259.03
FMR Inc9,893,1390.00551-3561295-26.46930430 Apr 20258.03
Fidelity Management and Research Company9,893,1390.00551-3561295-26.46930430 Apr 20258.03

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
23 Dec 2024-Dr. Serge Saxonov, PhD--67,463--
23 Dec 2024-Dr. Serge Saxonov, PhD1.2014,400884,574--
22 Nov 2024-Dr. Benjamin J. Hindson, PhD13.6979,485339,897--
21 Nov 2024-Dr. Serge Saxonov, PhD--879,267--
22 Nov 2024-Dr. Serge Saxonov, PhD13.6991,612872,574--
14 Nov 2024-Dr. Serge Saxonov, PhD--881,117--
23 Oct 2024-Mr. Adam S. Taich--201,704--
17 Mar 2025-Mr. Adam S. Taich--335,632--
30 Aug 2024-Dr. Sarah A. Teichmann--19,002--
22 Aug 2024-Dr. Serge Saxonov, PhD22.53152,053882,467--
22 Aug 2024-Dr. Benjamin J. Hindson, PhD22.5398,027345,704--
22 Aug 2024-Mr. Justin J. McAnear22.5366,710143,242--
31 Jul 2024-Mr. Alan V. Mateo--21,691--
11 Jun 2024-Mr. John R. Stuelpnagel, D.V.M.--344,250--
11 Jun 2024-Ms. Kimberly J. Popovits--13,259--
11 Jun 2024-Dr. Mathai Mammen, M.D.,PhD--180,259--
11 Jun 2024-Dr. Shehnaaz Suliman, M.D.--13,259--
29 May 2024-Dr. Serge Saxonov, PhD--889,216--
22 May 2024-Dr. Serge Saxonov, PhD24.30118,529889,641--
22 May 2024-Dr. Benjamin J. Hindson, PhD24.3099,329350,055--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.